Advertisement

Topics

Companies Related to "Plasma Protein Therapeutics Association" [Most Relevant Company Matches] [Advanced Search Results] RSS

05:33 EDT 18th October 2017 | BioPortfolio

Here are the most relevant search results for "Plasma Protein Therapeutics Association" found in our extensive corporate database of over 50,000 company records.

Showing "Plasma Protein Therapeutics Association" Companies 1–25 of 3,800+

Extremely Relevant

PPTA Global

The Plasma Protein Therapeutics Association (PPTA) is the primary advocate for the world's leading source plasma collectors and producers of plasma-based and recombinant biological therapeutics. The medicines produced by PPTA members are used in treating life-threatening diseases and serious medical conditions including bleeding disorders, immune system deficiencies, alpha-1 antitrypsin deficienci...


Plasma Protein Therapeutics Association

Plasma Protein Therapeutics Association (PPTA)


Relevant

CSL Behring

CSL Behring is a leader in the plasma protein therapeutics industry. Committed to saving lives and improving the quality of life for people with rare and serious diseases, the company manufactures and markets a range of plasma-derived and recombinant therapies worldwide.

ADMA Biologics, Inc.

ADMA is a clinical stage biotechnology company which focuses its efforts on the development and commercialization of human plasma and plasma-derived therapeutics. ADMA’s mission is to develop and commercialize plasma-derived, human immune globulins targeted at niche patient populations with unmet medical needs. In addition, ADMA operates ADMA BioCente...

Anaphore Inc.

Anaphore is developing a new class of protein pharmaceuticals to address significant unmet medical needs for patients with serious diseases. The company's Atrimer technology platform originates in tetranectin, a human plasma protein of trivalent structure. Each of the three binding domains comprises five distinct amino-acid loops that can be programmed to bind potently and specifically to virtuall...

Perlan Therapeutics

Perlan Therapeutics is an innovative developer of protein-based pharmaceuticals. The company's proprietary Multi-Valenceâ„¢ technology platform is the basis for the development of cost-effective protein-based therapeutics and diagnostic products that are characterized by increased binding avidity.

Plasma Surgical

Founded in 2000, Plasma Surgical is a global company committed to advancing surgical technology that enhances the care and safety of patients during medical procedures. The company’s most revolutionary enhancement is the application of plasma surgery, where pure plasma is used to efficiently cut and coagulate tissue.

Xencor

Since 1997, Xencor has built the most powerful protein engineering technology platform in the biotechnology industry. Its versatility is evidenced by our success in developing two classes of superior protein drug candidates: XmAb™ antibody therapeutics and XPro™ protein therapeutics. Because we can engineer the affinity and specificity of protein-protein interactions, we are also generating en...

Protein Therapeutics, Inc.

Protein Therapeutics, Inc. was founded in 1997 to discover and develop new therapies for chronic diseases.The initial focus of the company is to develop an oral formulation of human immunoglobulin (IgPO) to treat adult and juvenile rheumatoid arthritis, crippling diseases that affect more than 2.1 million people in the United States.Upon successful completion of this goal, Protein Therapeutics wil...

PX’Therapeutics SA

PX’Therapeutics, located in Grenoble and Lyon (France) and with a sales office in Cambridge (MA, USA), offers early stage research and cGMP manufacturing contracts focusing on the development of protein therapeutics, monoclonal antibodies and recombinant vaccines. PX’Therapeutics proposes custom programs targeting the generation of murine antibod...

ASI Technology

ASI Technology is a small business specializing in the development of advanced patented technologies in support of DOD and commercial organizations. This corporation owns two patented plasma technologies: 1. Plasma Sound Reduction 2. Plasma Decontamination & Sterilization From 1999 to 2003 we pioneered plasma antenna technology developing this new technology for DOD and commercial applications...

Proteostasis Therapeutics

Proteostasis Therapeutics is discovering “Proteostasis Regulators” (PRs), small molecule drugs that restore proper protein function to treat neurodegenerative, metabolic, genetic and inflammatory disorders. The Proteostasis Network (PN) is the cellular machinery responsible for protein folding, trafficking and clearance, and it can become imbalanced ...

Hemasol

Hemosol BioPharma Inc. is a privately held specialty biopharmaceutical company wholly owned by Catalyst Fund Limited Partnership II. The Company is focused primarily on the development and manufacture of blood related protein based therapeutic products. The Company's activities are focused in the following three areas: Implementation of the "Cascade" technology for the isolation and purificatio...

Velico Medical, Inc.

Velico Medical, Inc. is a clinical-stage company developing proprietary technologies intended to make blood transfusions safer, more effective and less costly. The Company’s leading product-candidate is a technology to enable the spray drying of plasma to improve its availability and eliminate costs related to frozen plasma, the current standard of care. ...

BaroFold, Inc.

BaroFold is applying its Pressure Enabled Protein Manufacturing (PreEMT™) Technology to transform inclusion body refolding and improve the efficacy and safety of a wide variety of protein therapeutics for its industry partners. PreEMT technology has been shown to remove protein aggregates, improving product safety for both new-drug entities and biosim...

XL-protein GmbH

XL-protein is a privately owned biopharmaceutical company based in Freising, Germany, which exploits its proprietary PASylation® technology to develop biologics with extended plasma half-life and enhanced in vivo activity. PASylation is a fully biological technology that can be applied both to approved biopharmaceuticals to yield second generation drugs...

Proteostasis Therapeutics and Elan Corporation

Proteostasis Therapeutics is developing “Proteostasis Regulators” (PRs), small molecule drugs that restore proper protein function or remove misfolded and aggregated proteins to treat neurodegenerative, metabolic, genetic and inflammatory disorders. The Proteostasis Network is the cellular machinery responsible for protein folding, trafficking and ...

Consortium for Plasma Science LLC

The Consortium for Plasma Science, LLC, was formed in January 1997 to support the development of a universal approach to eradicate pathogens in whole blood plasma. The Consortium is cofunded by Alpha Therapeutic Corporation, a subsidiary of Mitsubishi Pharma Corporation; Aventis Behring; Baxter Healthcare Corporation; and Bayer Corporation.The Member companies have agreed on a focused strategy to ...

Relay Therapeutics

Relay Therapeutics is committed to discovering and developing medicines that will make a transformative difference for patients by building the first dedicated drug discovery pipeline centered on protein motion. Bringing together the latest scientific advances in structural biology, biophysics, computation, chemistry and biology, Relay’s drug discovery ...

Pure Protein, L.L.C.

Pure Protein is an HLA Center of Excellence - developing immunology tools for therapeutic and diagnostic applications in solid organ and stem cell transplantation, cross-reactive antibody screening, and major autoimmune diseases. Pure Protein was formed in 1999 to commercialize research developed at the University of Oklahoma Health Sciences Center. Pure T...

Gryphon Sciences

Gryphon can generate novel or improved protein therapeutics using chemistry alone. This positions Gryphon to benefit from the revolution in genomics and proteomics that has identified countless new potential protein therapeutics. Gryphon uses two technologies that allow it to rapidly produce proteins of medical interest. These technologies form a powerful drug development platform, which Gryphon h...

Aileron Therapeutics & Roche

Headquartered in Cambridge, Massachusetts, Aileron Therapeutics is a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptide Therapeutics. Stapled Peptides are a breakthrough solution to address thousands of therapeutically important yet currently undruggable targets. Stapled Peptides have demonstrated their unique ...

Lectus Therapeutics Limited

Lectus Therapeutics Limited is a UK-based drug discovery and development company, specialising in the discovery and development of best- and first-in-class ion channel therapeutics for urinary bladder disorders, pain and angina.Lectus, which began operations in the summer of 2003, exploits the power of its proprietary functional proteomics platform, LEPTICS® (Leveraged Enabling Proteomics Technol...

Context Therapeutics

Context Therapeutics is a private, Philadelphia, PA-based biotechnology company dedicated to creating new medicines to treat Sigma1-associated diseases. The company leverages breakthrough science on the biochemistry of Sigma1 protein, the role of Sigma1 in regulating client protein homeostasis, and the role of Sigma1 in disease to develop novel drugs targe...


More From BioPortfolio on "Plasma Protein Therapeutics Association"

Quick Search
Advertisement
 

Corporate Database Quicklinks